Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing.

Milosevic D, Mills JR, Campion MB, Vidal-Folch N, Voss JS, Halling KC, Highsmith WE, Liu MC, Kipp BR, Grebe SKG.

Clin Chem. 2018 Dec;64(12):1732-1742. doi: 10.1373/clinchem.2018.291278. Epub 2018 Sep 20.

PMID:
30237149
2.

A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference.

Mills JR, Kohlhagen MC, Willrich MAV, Kourelis T, Dispenzieri A, Murray DL.

Blood. 2018 Aug 9;132(6):670-672. doi: 10.1182/blood-2018-05-848986. Epub 2018 Jun 11. No abstract available.

PMID:
29891533
3.

Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.

Cornec D, Kabat BF, Mills JR, Cheu M, Hummel AM, Schroeder DR, Cascino MD, Brunetta P, Murray DL, Snyder MR, Fervenza F, Hoffman GS, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Barnidge DR, Specks U.

Rheumatology (Oxford). 2018 Apr 1;57(4):639-650. doi: 10.1093/rheumatology/kex484.

PMID:
29340623
4.

Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.

Gleeson FC, Voss JS, Kipp BR, Kerr SE, Van Arnam JS, Mills JR, Marcou CA, Schneider AR, Tu ZJ, Henry MR, Levy MJ.

Oncotarget. 2017 Jun 28;8(55):93464-93475. doi: 10.18632/oncotarget.18750. eCollection 2017 Nov 7.

5.

DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN.

Dasari S, Alexander MP, Vrana JA, Theis JD, Mills JR, Negron V, Sethi S, Dispenzieri A, Highsmith WE Jr, Nasr SH, Kurtin PJ.

J Am Soc Nephrol. 2018 Jan;29(1):51-56. doi: 10.1681/ASN.2017030306. Epub 2017 Nov 2.

PMID:
29097623
6.

High sensitivity blood-based M-protein detection in sCR patients with multiple myeloma.

Mills JR, Barnidge DR, Dispenzieri A, Murray DL.

Blood Cancer J. 2017 Aug 25;7(8):e590. doi: 10.1038/bcj.2017.75.

7.

Unilateral vestibular schwannoma and meningiomas in a patient with PIK3CA-related segmental overgrowth: Co-occurrence of mosaicism for 2 rare disorders.

Mills JR, Moyer AM, Kipp BR, Poplawski AB, Messiaen LM, Babovic-Vuksanovic D.

Clin Genet. 2018 Jan;93(1):187-190. doi: 10.1111/cge.13099. Epub 2017 Nov 29.

PMID:
28737257
8.

Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling.

Penafuerte C, Feldhammer M, Mills JR, Vinette V, Pike KA, Hall A, Migon E, Karsenty G, Pelletier J, Zogopoulos G, Tremblay ML.

Oncoimmunology. 2017 Apr 28;6(6):e1321185. doi: 10.1080/2162402X.2017.1321185. eCollection 2017.

9.

Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).

Gupta S, Zhang J, Milosevic D, Mills JR, Grebe SK, Smith SC, Erickson LA.

Endocr Pathol. 2017 Sep;28(3):253-268. doi: 10.1007/s12022-017-9489-0.

PMID:
28646318
10.

Apolipoprotein A-IV-Associated Cardiac Amyloidosis.

Bois MC, Dasari S, Mills JR, Theis J, Highsmith WE, Vrana JA, Grogan M, Dispenzieri A, Kurtin PJ, Maleszewski JJ.

J Am Coll Cardiol. 2017 May 2;69(17):2248-2249. doi: 10.1016/j.jacc.2017.02.047. No abstract available.

11.

The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.

Milani P, Murray DL, Barnidge DR, Kohlhagen MC, Mills JR, Merlini G, Dasari S, Dispenzieri A.

Am J Hematol. 2017 Aug;92(8):772-779. doi: 10.1002/ajh.24772. Epub 2017 Jun 1.

12.

Precision Medicine-Right Treatment, Right Patient, Right Time, Wrong Approach?

Mills JR.

Clin Chem. 2017 Apr;63(4):928-929. doi: 10.1373/clinchem.2016.267963. No abstract available.

13.

Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype.

Nasr SH, Dasari S, Mills JR, Theis JD, Zimmermann MT, Fonseca R, Vrana JA, Lester SJ, McLaughlin BM, Gillespie R, Highsmith WE Jr, Lee JJ, Dispenzieri A, Kurtin PJ.

J Am Soc Nephrol. 2017 Feb;28(2):431-438. doi: 10.1681/ASN.2016090951. Epub 2017 Jan 3.

14.

Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.

Mills JR, Kohlhagen MC, Dasari S, Vanderboom PM, Kyle RA, Katzmann JA, Willrich MA, Barnidge DR, Dispenzieri A, Murray DL.

Clin Chem. 2016 Oct;62(10):1334-44. doi: 10.1373/clinchem.2015.253740. Epub 2016 Aug 18.

15.

Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.

Kohlhagen MC, Barnidge DR, Mills JR, Stoner J, Gurtner KM, Liptac AM, Lofgren DI, Vanderboom PM, Dispenzieri A, Katzmann JA, Willrich MA, Snyder MR, Murray DL.

Clin Chem. 2016 Oct;62(10):1345-52. doi: 10.1373/clinchem.2015.253781. Epub 2016 Aug 11.

16.

CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A.

Chu J, Galicia-Vázquez G, Cencic R, Mills JR, Katigbak A, Porco JA Jr, Pelletier J.

Cell Rep. 2016 Jun 14;15(11):2340-7. doi: 10.1016/j.celrep.2016.05.005. Epub 2016 May 26.

17.

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis.

Mills JR, Cornec D, Dasari S, Ladwig PM, Hummel AM, Cheu M, Murray DL, Willrich MA, Snyder MR, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Specks U, Barnidge DR.

Anal Chem. 2016 Jun 21;88(12):6317-25. doi: 10.1021/acs.analchem.6b00544. Epub 2016 Jun 3.

18.

Contemporary celiac disease diagnosis: is a biopsy avoidable?

Mills JR, Murray JA.

Curr Opin Gastroenterol. 2016 Mar;32(2):80-5. doi: 10.1097/MOG.0000000000000245. Review.

PMID:
26784474
19.

Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration.

Bergen HR 3rd, Dasari S, Dispenzieri A, Mills JR, Ramirez-Alvarado M, Tschumper RC, Jelinek DF, Barnidge DR, Murray DL.

Clin Chem. 2016 Jan;62(1):243-51. doi: 10.1373/clinchem.2015.242651. Epub 2015 Oct 1.

20.

Fluctuating serum aspartate aminotransferase activity in a complicated pregnancy.

Mills JR, Greene DN, Bainton J, Lorey TS, Baumann NA.

Clin Chem. 2015 Oct;61(10):1241-4. doi: 10.1373/clinchem.2014.228247. No abstract available.

21.
22.

Detecting monoclonal immunoglobulins in human serum using mass spectrometry.

Mills JR, Barnidge DR, Murray DL.

Methods. 2015 Jun 15;81:56-65. doi: 10.1016/j.ymeth.2015.04.020. Epub 2015 Apr 24.

PMID:
25916620
23.

To monitor dabigatran or not: a matter of patient safety.

Ketha H, Mills JR.

Clin Chem. 2015 May;61(5):691-3. doi: 10.1373/clinchem.2014.232207. Epub 2015 Feb 4. No abstract available.

24.

Suppression of the DHX9 helicase induces premature senescence in human diploid fibroblasts in a p53-dependent manner.

Lee T, Di Paola D, Malina A, Mills JR, Kreps A, Grosse F, Tang H, Zannis-Hadjopoulos M, Larsson O, Pelletier J.

J Biol Chem. 2014 Aug 15;289(33):22798-814. doi: 10.1074/jbc.M114.568535. Epub 2014 Jul 2.

25.

Repurposing CRISPR/Cas9 for in situ functional assays.

Malina A, Mills JR, Cencic R, Yan Y, Fraser J, Schippers LM, Paquet M, Dostie J, Pelletier J.

Genes Dev. 2013 Dec 1;27(23):2602-14. doi: 10.1101/gad.227132.113.

26.

RNAi screening uncovers Dhx9 as a modifier of ABT-737 resistance in an Eμ-myc/Bcl-2 mouse model.

Mills JR, Malina A, Lee T, Di Paola D, Larsson O, Miething C, Grosse F, Tang H, Zannis-Hadjopoulos M, Lowe SW, Pelletier J.

Blood. 2013 Apr 25;121(17):3402-12. doi: 10.1182/blood-2012-06-434365. Epub 2013 Feb 25.

27.

Emerging therapeutics targeting mRNA translation.

Malina A, Mills JR, Pelletier J.

Cold Spring Harb Perspect Biol. 2012 Apr 1;4(4):a012377. doi: 10.1101/cshperspect.a012377.

28.

Inhibiting mitochondrial-dependent proteolysis of Mcl-1 promotes resistance to DNA damage.

Mills JR, Malina A, Pelletier J.

Cell Cycle. 2012 Jan 1;11(1):88-98. doi: 10.4161/cc.11.1.18408. Epub 2012 Jan 1.

PMID:
22185779
29.

Targeting protein synthesis in a Myc/mTOR-driven model of anorexia-cachexia syndrome delays its onset and prolongs survival.

Robert F, Mills JR, Agenor A, Wang D, DiMarco S, Cencic R, Tremblay ML, Gallouzi IE, Hekimi S, Wing SS, Pelletier J.

Cancer Res. 2012 Feb 1;72(3):747-56. doi: 10.1158/0008-5472.CAN-11-2739. Epub 2011 Dec 12.

30.

Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site.

Warr MR, Mills JR, Nguyen M, Lemaire-Ewing S, Baardsnes J, Sun KL, Malina A, Young JC, Jeyaraju DV, O'Connor-McCourt M, Pellegrini L, Pelletier J, Shore GC.

J Biol Chem. 2011 Jul 15;286(28):25098-107. doi: 10.1074/jbc.M111.218321. Epub 2011 May 25.

31.
32.

Uncoupling stress granule assembly and translation initiation inhibition.

Mokas S, Mills JR, Garreau C, Fournier MJ, Robert F, Arya P, Kaufman RJ, Pelletier J, Mazroui R.

Mol Biol Cell. 2009 Jun;20(11):2673-83. doi: 10.1091/mbc.E08-10-1061. Epub 2009 Apr 15.

33.

Tumorigenic activity and therapeutic inhibition of Rheb GTPase.

Mavrakis KJ, Zhu H, Silva RL, Mills JR, Teruya-Feldstein J, Lowe SW, Tam W, Pelletier J, Wendel HG.

Genes Dev. 2008 Aug 15;22(16):2178-88. doi: 10.1101/gad.1690808.

34.

mTORC1 promotes survival through translational control of Mcl-1.

Mills JR, Hippo Y, Robert F, Chen SM, Malina A, Lin CJ, Trojahn U, Wendel HG, Charest A, Bronson RT, Kogan SC, Nadon R, Housman DE, Lowe SW, Pelletier J.

Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10853-8. doi: 10.1073/pnas.0804821105. Epub 2008 Jul 29.

35.

c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.

Lin CJ, Cencic R, Mills JR, Robert F, Pelletier J.

Cancer Res. 2008 Jul 1;68(13):5326-34. doi: 10.1158/0008-5472.CAN-07-5876. Erratum in: Cancer Res. 2008 Sep 1;68(17):7246.

36.

Dissecting eIF4E action in tumorigenesis.

Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Teruya-Feldstein J, Pelletier J, Lowe SW.

Genes Dev. 2007 Dec 15;21(24):3232-7. Epub 2007 Nov 30.

37.

Hubble Space Telescope Imaging of Neptune's Cloud Structure in 1994.

Hammel HB, Lockwood GW, Mills JR, Barnet CD.

Science. 1995 Jun 23;268(5218):1740-2.

PMID:
17834994
38.

HST imaging of atmospheric phenomena created by the impact of comet Shoemaker-Levy 9.

Hammel HB, Beebe RF, Ingersoll AP, Orton GS, Mills JR, Simon AA, Chodas P, Clarke JT, De Jong E, Dowling TE, et al.

Science. 1995 Mar 3;267(5202):1288-96.

PMID:
7871425
39.

Presentation of Yersinia enterocolitica enteritis in children.

Naqvi SH, Swierkosz EM, Gerard J, Mills JR.

Pediatr Infect Dis J. 1993 May;12(5):386-9.

PMID:
8327299
40.

'Orthodontic relapse'.

Mills JR.

Br Dent J. 1992 Jun 6;172(11):397-8. No abstract available.

PMID:
1530740
41.

Treatment for abused children: when is a partial solution acceptable?

Graziano AM, Mills JR.

Child Abuse Negl. 1992;16(2):217-28. Review.

PMID:
1559170
42.

The effect of functional appliances on the skeletal pattern.

Mills JR.

Br J Orthod. 1991 Nov;18(4):267-75.

PMID:
1838280
43.

Annihilation rate of positronium in a magnetic field.

Mills Jr AP.

Phys Rev A. 1990 Jan 1;41(1):502-503. No abstract available.

PMID:
9902894
44.

A retrospective cephalometric study of Class I patients.

Mills JR.

Br J Orthod. 1989 Nov;16(4):291-2. No abstract available.

PMID:
2819008
45.

An interview with Professor Mills.

Mills JR.

Br J Orthod. 1987 Nov;14(4):309-12. No abstract available.

PMID:
3325098
46.

Future manpower requirements for orthodontics undertaken in the general dental service.

Mills JR.

Br J Orthod. 1986 Jul;13(3):183-4. No abstract available.

PMID:
3460634
47.

The effect of two contrasting forms of orthodontic treatment on the facial profile.

Looi LK, Mills JR.

Am J Orthod. 1986 Jun;89(6):507-17.

PMID:
3459364
48.

A clinician looks at facial growth.

Mills JR.

Br J Orthod. 1983 Apr;10(2):58-72. Review.

PMID:
6342659
49.

The place of research in orthodontic education.

Mills JR.

Br J Orthod. 1982 Apr;9(2):67-9.

PMID:
6952926
50.

Hypercalcemia with ovarian carcinoma: evidence of a pathogenetic role for prostaglandins.

Josse RG, Wilson DR, Heersche JN, Mills JR, Murray TM.

Cancer. 1981 Sep 1;48(5):1233-41.

PMID:
7272955

Supplemental Content

Loading ...
Support Center